Journal of Addiction Medicine

Article	Citations
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	82
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	53
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	44
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	41
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	40
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	39
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	39
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	33
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	28
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	27
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	27
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	26
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	25
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	25
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	25
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	24
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	24
Letter to the Editor (RE: Polles et al)	23
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	22
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	21
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	20
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	20
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	19
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	19
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	19

Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	19
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	18
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	18
Use of Cannabinoids by People Who Consume Kratom in the United States	17
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	16
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	16
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	16
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	16
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	15
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	14
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	14
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	13
The Need for Multidisciplinary Hospital Teams for Injection Drug Use-related Infective Endocarditis	13
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	13
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	12
A Hospital-based Managed Alcohol Program in a Canadian Setting	11
Fentanyl Test Strips for Harm Reduction: A Scoping Review	11
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	11
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	11
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat among US Adults	11
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	11
Climate Change and the Opioid Epidemic	11
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	11
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	11
Current State of Perioperative Buprenorphine Management—A National Provider Survey	11
Response to: “Prevalence of Kratom Use Disorder Among Kratom Consumers”	10
The Difficulties in Finding the Relevant Associations between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	10
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	10
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	10
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	10
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	9
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	9
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	9
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	9
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	9
Letter in Reply	9
Retention With Medication for Opioid Use Disorder: The Role of the Primary Care Relationship	9
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	9
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	8
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	8
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	8
Addiction Services for Veterans: Opportunities in Acute Care	8
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	8
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	8
Maternal Cannabis Use in the Perinatal Period: Data From the Pregnancy Risk Assessment Monitoring System Marijuana Supplement, 2016–2018	8
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	8
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	8
A Scoping Review of Youth Overdose Prevention Interventions	8
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	8
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	8

Complexities in Assessing Pregnancy-related Outcomes Among Patients Receiving Interdisciplinary Treatment for an Opioid Use Disorder	8
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	7
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	7
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	7
Prevalence of Kratom Use Disorder Among Kratom Consumers	7
Letter in Reply	7
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	7
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	7
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	7
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	7
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	7
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	7
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	7
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	7
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	7
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	7
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	7
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	7
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	7
Direct Induction of Buprenorphine Extended-Release: A Case Report	7
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	7
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	7
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	7
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	6
Challenges of Drug Testing in Addiction Treatment	6
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	6
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	6
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	6
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	6
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	6
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
Response to Martins et al.	6
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	5
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	5
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	5
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	5
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	5
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	5
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	5
Use of Practices to Reduce of Sudden Unexpected Infant Death among Caregivers of Opioid Exposed Newborns	5
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	5
Response to the Federation of State Physician Health Program's Commentary	5
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	5
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	5
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	5
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	5
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	5
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	4
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	4
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	4
Does Labetalol Trigger False Positive Drug Testing Results?	4
The First 100 Days: The Trump Administration and Changes to Addiction Policy	4
Exploring Preferences for Communication and Care among Hospitalized Patients with Opioid Use Disorder: A Qualitative Descriptive Study	4
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	4
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	4
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	4
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
2024 ASAM Annual Conference Poster Abstracts	4
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	4
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	4
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	4
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	4
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	4
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	4
The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup	4
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	4
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	4
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	4
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	4

A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic	4
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	4
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	4
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	4
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	4
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	4
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	4
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	4
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	4
Privacy and Digital Health: Causes for Concern and a Way Forward	4
Facilitating Integrated Perinatal Care for Families Affected by Substance Use	4
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	4
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service	4